Mast cells in human carotid atherosclerotic plaques are associated with intraplaque microvessel density and the occurrence of future cardiovascular events

European Heart Journal

Volumn 34, Issue 48, 2013, Pages 3699-3706

  Willems, Sanne ^a   Vink, Aryan ^a   Bot, Ilze ^b   Quax, Paul H A ^c   De Borst, Gert Jan ^a   De Vries, Jean Paul P M ^d   Van De Weg, Sander M ^a   Moll, Frans L ^a   Kuiper, Johan ^b   Kovanen, Petri T ^e   De Kleijn, Dominique P V ^a,f,g   Hoefer, Imo E ^a   Pasterkamp, Gerard ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ST ANTONIUS HOSPITAL   (Netherlands)

^e WIHURI RESEARCH INSTITUTE   (Finland)

^f ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^g NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Atherosclerosis; Inflammation; Intraplaque neovascularization; Mast cells; Unstable plaque

Indexed keywords

ADVERSE OUTCOME; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CAPILLARY DENSITY; CARDIOVASCULAR DISEASE; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MAST CELL; NEOVASCULARIZATION (PATHOLOGY); NEUTROPHIL; PHENOTYPE; PRIORITY JOURNAL;

ATHEROSCLEROSIS; INFLAMMATION; INTRAPLAQUE NEOVASCULARIZATION; MAST CELLS; UNSTABLE PLAQUE;

AGED; CARDIOVASCULAR DISEASES; CAROTID STENOSIS; CASE-CONTROL STUDIES; ENDARTERECTOMY, CAROTID; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MAST CELLS; MICROVESSELS; NEOVASCULARIZATION, PATHOLOGIC; PLAQUE, ATHEROSCLEROTIC; POSTOPERATIVE COMPLICATIONS; TREATMENT OUTCOME; TRYPTASES;

EID: 84891526510     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/eht186     Document Type: Article

References (32)

1. Libby P. Inflammation in atherosclerosis. Nature 2002;420:868-874.
2. Galli SJ, Tsai M. IgE and mast cells in allergic disease. Nat Med 2012;18:693-704.
3. Kovanen P, Kaartinen M, Paavonen T. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation 1995; 92:1084-1088.
4. Bot I, De Jager SC, Zernecke A, Lindstedt K, van Berkel TJ, Weber C, Biessen EA. Perivascular mast cells promote atherogenesis and induce plaque destabilization in apolipoprotein E-deficient mice. Circulation 2007;115:2516-2525.
5. Tang Y, Yang Y,Wang S, Huang T, Tang C, Xu Z, Sun Y. Mast cell degranulator compound 48-80 promotes atherosclerotic plaque in apolipoprotein E knockout mice with perivascular common carotid collar placement. Chin Med J 2009;122:319-325.
6. Guo T, Chen WQ, Zhang C, Zhao YX, Zhang Y. Chymase activity is closely related with plaque vulnerability in a hamster model of atherosclerosis. Atherosclerosis 2009; 207:59-67.
7. Sun J, Sukhova GK, Wolters PJ, Yang M, Kitamoto S, Libby P, MacFarlane LA, Mallen-St Clair J, Shi GP. Mast cells promote atherosclerosis by releasing proinflammatory cytokines. Nat Med 2007;13:719-724.
8. Heikkilä HM, Trosien J, Metso J, Jauhiainen M, Pentikäinen MO, Kovanen PT, Lindstedt KA. Mast cells promote atherosclerosis by inducing both an atherogenic lipid profile and vascular inflammation. J Cell Biochem 2010;109:615-623.
9. Smith DD, Tan X, RaveendranVV,TawfikO, Stechschulte DJ, Dileepan KN. Mast cell deficiency attenuates progression of atherosclerosis and hepatic steatosis in apolipoprotein E-null mice. Am J Physiol Heart Circ Physiol 2012;302:H2612-H2621.
10. Kessler DA, Langer RS, Pless NA, Folkman J. Mast cells and tumor angiogenesis. Int J Cancer 1976;18:703-9.
11. Kaartinen M, Pentilla A, Kovanen PT. Mast cells accompany microvessels in human coronary atheromas: Implications for intimal neovascularization and hemorrhage. Atherosclerosis 1996;123:123-131.
12. Jeziorska M,Woolley DE. Local neovascularization and cellular composition within vulnerable regions of atherosclerotic plaques of human carotid arteries. J Pathol 1999;188:189-196.
13. Atkinson J, Harlan C, Harlan G, Virmani R. The association of mast cells and atherosclerosis: A morphologic study of early atherosclerotic lesions in young people. Hum Pathol 1994;25:154-159.
14. Kamat B, Galli S, Barger A, Lainey L, Silverman K. Neovascularization and coronary atherosclerotic plaque: Cinematographic localization and quantitative histologic analysis. Hum Pathol 1987;18:1036-1042.
15. Lappalainen H, Laine P, Pentikäinen MO, Sajantila A, Kovanen PT. Mast cells in neovascularized human coronary plaques store and secrete basic fibroblast growth factor, a potent angiogenic mediator. Arterioscler Thromb Vasc Biol 2004;24: 1880-1885.
16. Hellings WE, PeetersW, Moll FL, Piers SR, van Setten J, Van der Spek PJ, de Vries JP, Seldenrijk KA, de Bruin PC, Vink A, Velema E, de Kleijn DP, Pasterkamp G. Composition of carotid atherosclerotic plaque is associated with cardiovascular outcome: A prognostic study. Circulation 2010;121:1941-1950.
17. Verhoeven BA, Velema E, Schoneveld AH, de Vries JP, de Bruin P, Seldenrijk CA, de Kleijn DP, Busser E, van der Graaf Y, Moll F, Pasterkamp G. Athero-express: Differential atherosclerotic plaque expression of mRNA and protein in relation to cardiovascular events and patient characteristics. Rationale and design. Eur J Epidemiol 2004;19:1127-1133.
18. Walker MD, Marler JR, Goldstein M, Grady PA, Toole JF, Baker WH, Castaldo JE, Chambless LE, Moore WS, Robertson JT, Young B, Howard VJ, Purvis S, VernonDD, Needham K, Beck P, Celani VJ, Sauerbeck L, von Rajcs JA, Atkins D. Endarterectomy for asymptomatic carotid artery stenosis. Executive committee for the asymptomatic carotid atherosclerosis study. JAMA 1995;273:1421-1428.
19. Halliday A, Mansfield A, Marro J, Peto C, Peto R, Potter J, Thomas D. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: Randomised controlled trial. Lancet 2004;363: 1491-1502.
20. Rothwell PM, Eliasziw M, Gutnikov SA, Fox AJ, Taylor DW, Mayberg MR, Warlow CP, Barnett HJ. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 2003;361: 107-116.
21. Ribatti D, Levi-Schaffer F, Kovanen PT. Inflammatory angiogenesis in atherogenesis: A double-edged sword. Ann Med 2008;40:606-621.
22. Bot I, Biessen EA. Mast cells in atherosclerosis. Thromb Haemost 2011; 106:820-826.
23. Kaartinen M, van der Wal A, van der Loos CM, Piek JJ, Koch KT, Becker AE, Kovanen PT. Mast cell infiltration in acute coronary syndromes: Implications for plaque rupture. J Am Coll Cardiol 1998;32:606-612.
24. Kaartinen M, Penttilä A, Kovanen PT. Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture. Circulation 1994;90:1669-1678.
25. Jeziorska M, McCollum C, Woolley DE. Mast cell distribution, activation, and phenotype in atherosclerotic lesions of human carotid arteries. J Pathol 1997;182: 115-122.
26. Kovanen P. Mast cells in atherogenesis: Actions and reactions. Curr Atheroscler Rep 2009;11:214-219.
27. Kovanen P. Mast cells and degradation of pericellular and extracellular matrices: Potential contributions to erosion, rupture and intraplaque haemorrhage of atherosclerotic plaques. Biochem Soc Trans 2007;35:857-861.
28. Xiang M, Sun J, Lin Y, Zhang J, Chen H, Yang D,Wang J, Shi GP. Usefulness of serum tryptase level as an independent biomarker for coronary plaque instability in a Chinese population. Atherosclerosis 2011;215:494-499.
29. Deliargyris EN, Upadhya B, Sane DC, Dehmer GJ, Pye J, Smith SC, Boucher WS, Theoharides TC. Mast cell tryptase: A new biomarker in patients with stable coronary artery disease. Atherosclerosis 2005;178:381-386.
30. Upadhya B, Kontos J, Ardeshirpour F, Pye J, BoucherW, Theoharides T, Dehmer G, Deliargyris E. Relation of serum levels of mast cell tryptase of left ventricular systolic function, left ventricular volume or congestive heart failure. J Card Fail 2004;10: 31-35.
31. Kervinen H, Kaartinen M, Mäkynen H, Palosuo T, Mänttäri M, Kovanen PT. Serum tryptase levels in acute coronary syndromes. Int J Cardiol 2005;104:138-143.
32. van Haelst PL, Timmer JR, Crijns HJ, Kauffman HF, Gans RO, van Doormaal JJ. No long-lasting or intermittent mast cell activation in acute coronary syndromes. Int J Cardiol 2001;78:75-80.